C4MH - Florida's Leader in Low T Care.

C4MH Low T Clinic - Testosterone Replacement Therapy

As the leaders in Safe, Affordable and Convenient Testosterone Replacement Therapy C4MH’s physicians and staff will design an individualized treatment plan for your specific needs. In business since 2011, we now offer 18 C4MH Low T clinic locations along West Florida.

Why Testosterone Replacement at C4MH?

1. EXCLUSIVE: Testosterone Replacement Therapy (TRT) is all we do.

2. AFFORDABLE: C4MH pricing ends the "only for the wealthy" mentality.

3. CONVENIENT: The C4MH "treatment" protocol gets you in and out in 10 minutes or less.
(Initial exam takes approximately 60 minutes)

4. SAFE: C4MH physician’s practice within the prevailing professional standard of care.

Common phrases that Low T researchers use to find our clinic by include: Testosterone Replacement Therapy, Male Hormone Therapy, Mens Sexual Health Restoration, Testosterone and Antiaging.

Get Started With Our $45 Express Treatment Plan (ETP)

Learn More About Low T and Testosterone Replacement Therapy

Medical Experts Now Agree

Testosterone is SAFE!

January 2015

Mayo Clinic Journal

“In summary, there is no convincing evidence of increased CV (cardio vascular) risks with testosterone therapy. On the contrary, there appears to be a strong beneficial relationship between normal testosterone levels and CV health that has not yet been widely appreciated.”

September 17, 2014

FDA Announces:

No Conclusive Evidence of increased Cardio Vascular Events Linked to Testosterone Replacement.

July 2, 2014

National Institutes of Health and the University of Texas Medical Branch

THE LARGEST AND LONGEST DOUBLE COHORT MEDICAL STUDY 25,000 MEN OVER 8 YEARS FINDS:

1) No Link to Increased Risk of Heart Attacks.

2) Men At A Greater Risk for Heart Problems Had Lower Rate of Heart Attacks Compared to Those That Did Not Receive Testosterone Injections.

No Cardiovascular Risks with Testosterone Therapy

American College of Cardiology (ACC) Scientific Sessions 2015

Data from a meta-analysis and an observational study suggest testosterone therapy is not associated with cardiovascular (CV) events in men.